Graham Phillips is a second-generation pharmacist and a Fellow of the Royal Pharmaceutical Society (FRPharmS)—an honour reserved for the top 1% of the profession. After 35 years at the pinnacle of UK clinical pharmacy, Graham has become a leading international reformer, advocating for a shift from “symptom management” to root-cause metabolic healing.
Global Leadership in the GLP-1 Era
Graham is an acknowledged international expert on the clinical application and “off-ramping” of GLP-1 receptor agonists (such as Wegovy and Mounjaro).
Chair, PHC International Conference (2025)
Graham recently chaired the definitive panel on GLP-1s for the Public Health Collaboration, leading a debate with world-renowned experts including Dr. Eric Westman and Dr. David Unwin on the risks of muscle loss and the necessity of “off-boarding” strategies.
Chair, KetoLive (2025)
Graham presided over the GLP-1 clinical tracks at the KetoLive international conference, focusing on the intersection of precision nutrition and pharmaceutical intervention.
A Clinical “Exit Strategist”
Graham is a vocal critic of the “Wild West” of online prescribing. He is currently pioneering “micro-dosing” protocols and precision nutrition frameworks that allow patients to use these drugs as a bridge to health, rather than a lifelong dependency.
Graham’s authority is built on decades of leadership within the UK healthcare system:
Pharmacist of the Year & Leader of the Year: Recipient of the profession’s highest accolades for his innovative approach to community health.
National Policy Maker: Served four years on the Council of the Royal Pharmaceutical Society and acted as the Chair of Education, shaping how the next generation of pharmacists are trained.
NHS Reformer: Contributed to the NHS Cancer Reform Strategy and served as a Primary Care Trust (PCT) Prescribing Lead.
Trustee of the PHC: Currently serves as a Trustee and Vice-Chair of the Public Health Collaboration, a charity at the forefront of the UK’s metabolic health revolution.
This is a free pharmacist-led community for people who want to lose weight, reduce food noise, and come off GLP-1s without rebound regain. Join this group if you:
In this video, Graham leads a critical discussion on the “Wild West” of GLP-1 prescribing and the vital importance of protecting muscle mass and bone density during weight loss.
Known as “The Pharmacist Who Gave Up Drugs,” Graham founded ProLongevity after realizing that conventional medicine often sells patients a “lifelong subscription” to a problem it never intends to solve.
By combining his deep pharmacological knowledge with Continuous Glucose Monitoring (CGM), he helps patients reverse Type 2 Diabetes and metabolic dysfunction, ultimately helping them de-prescribe safely and effectively.